Year 2014,
Issue: 4, 290 - 292, 01.12.2014
Abstract
Ankylosing Spondylitis AS is an inflammatory disease characterized by involvement of the spinal joints and adjacent structures leading to bone fusion. Although secondary amyloidosis is the most common renal involvement type in AS, there are few reports regarding to other glomerular disorders including association of IgA nephritis with AS. We present a 24-yearold male patient that admitted with intermittent hematuria and proteinuria while he was followed up for AS disease and diagnosed as chronic IgA nephritis by renal biopsy
References
- Calvo-Río V, Loricera J, Martín L, Ortiz-Sanjuán F, Alvarez L, González-Vela MC et al. Henoch-Schönlein purpura nephritis and IgA nephropathy: a comparative clinical study. Clin Exp Rheumatol 2013;31:45-51.
- Jacquet A, Francois H, Frangie C, Yahiaoui Y, Ferlicot S, Micelli C. et al. IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy. Nephrol Dial Transplant 2009;24:3540-2.
- Singh G, Kumari N, Aggarwal A, Krishnani N, Misra R. Prevalence of subclinical amyloidosis in ankylosing spondylitis. J Rheumatol 2007;34:371–3.
- World MJ. Review of cases of IgA nephropathy. JR Army Med Corps 2013;159:90-3.
- Satko SG, Iskandar SS, Appel RG. IgA nephropathy and Reiter’s syndrome. Report of two cases and review of the literature. Nephron 2000;84:177-82.
- Matsuda M, Suzuki A, Miyagawa H, Shimizu S, Ikeda S. Coexistence of IgA nephropathy and undifferentiated spondyloarthropathy in a female patient. Clinical Rheumatology May 2006, Volume 25, Issue 3, pp 415-8.
- Peeters A.J, van den Wall Bake AW, Daha MR, Breeveld FC. Inflammatory bowel disease and ankylosing spondylitis associated with cutaneous vasculitis, glomerulonephritis, and circulating IgA immune complexes. Ann Rheum Dis 1990;49:638-40.
- Swaak A.J, Frankfort I, Menon RS, Pekelharing JM, Planten O. Absence of IgA nephropathy in patients with ankylosing spondylitis. Rheumatol Int 1986;6:145-9.
- Wall BA, Agudelo CA, Pisko EJ. Increased incidence of recurrent hematuria in ankylosing spondylitis: a possible association with IgA nephropathy. Rheumatol Int 1984;4:27-9.
- Calin A. Rarity of nephropathy in ankylosing spondylitis. Arthritis Rheum. 1982;25:1510.
- Levy-Clarke G, Nussenblatt R. Does anti-TNF therapy decrease the incidence of anterior uveitis in patients with ankylosing spondylitis? Nat Clin Pract Rheumatol 2006;2:72–3.
- Elewaut D, Matucci-Cerinic M. Treatment of ankylosing spondylitis and extraarticular manifestations in everyday rheumatology practice. Rheumatology (Oxford) 2009;48:1029–35.
- Song IH, Appel H, Haibel H, Loddenkemper C, Braun J, Sieper J. et al. New onset of Crohn’s disease during treatment of active ankylosing spondylitis with etanercept. J Rheumatol 2008;35:532–6.
- Braun J, Baraliakos X, Listing J, Davis J, van der Heijde D, Haibel H. et al. Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents. Arthritis Rheum 2007;57:639–47.
- Reynolds TL, Khan MA, Van der Linden S, Cleveland RP. Differences in HLA-B27 positive and negative patients with ankylosing spondylitis: study- of clinical disease activityaild concentration of serum IgA, C reactive protein, and, haptoglobin. Ann Rheum Dis 1991;50:154-7.
- Kobak S, Oksel F, Kabasakal Y, Doganavsargil E. Ankylosing spondylitis- related secondary amyloidosis responded well to etanercept: a report of three patients. Clin Rheumatol 2007;26:2191–4.
Year 2014,
Issue: 4, 290 - 292, 01.12.2014
Abstract
Ankilozan spondilit spinal eklemlerin inflamasyonu ile seyreden inflamatuar bir hastalıktır ve eklem yapışıklıkları kemiklerde birleşmeye neden olur. AS de izlenen renal hastalığın en yaygını sekonder amiloidoz olmasına rağmen diğer glomeruler tutulumlarda tanımlanmıştır. Maalesef literatürde yalnız çok az olguda AS li hastalarda IgA Nefriti rapor edilmiştir. Burada AS hastalığı nedeni ile takipteyken aralıklı hematüri ve proteinürinin tespit edildikten sonra, renal biyopsiyle kronik IgA Nefropatisi tanısı konulan 24 yaşında erkek hastayı sunduk
References
- Calvo-Río V, Loricera J, Martín L, Ortiz-Sanjuán F, Alvarez L, González-Vela MC et al. Henoch-Schönlein purpura nephritis and IgA nephropathy: a comparative clinical study. Clin Exp Rheumatol 2013;31:45-51.
- Jacquet A, Francois H, Frangie C, Yahiaoui Y, Ferlicot S, Micelli C. et al. IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy. Nephrol Dial Transplant 2009;24:3540-2.
- Singh G, Kumari N, Aggarwal A, Krishnani N, Misra R. Prevalence of subclinical amyloidosis in ankylosing spondylitis. J Rheumatol 2007;34:371–3.
- World MJ. Review of cases of IgA nephropathy. JR Army Med Corps 2013;159:90-3.
- Satko SG, Iskandar SS, Appel RG. IgA nephropathy and Reiter’s syndrome. Report of two cases and review of the literature. Nephron 2000;84:177-82.
- Matsuda M, Suzuki A, Miyagawa H, Shimizu S, Ikeda S. Coexistence of IgA nephropathy and undifferentiated spondyloarthropathy in a female patient. Clinical Rheumatology May 2006, Volume 25, Issue 3, pp 415-8.
- Peeters A.J, van den Wall Bake AW, Daha MR, Breeveld FC. Inflammatory bowel disease and ankylosing spondylitis associated with cutaneous vasculitis, glomerulonephritis, and circulating IgA immune complexes. Ann Rheum Dis 1990;49:638-40.
- Swaak A.J, Frankfort I, Menon RS, Pekelharing JM, Planten O. Absence of IgA nephropathy in patients with ankylosing spondylitis. Rheumatol Int 1986;6:145-9.
- Wall BA, Agudelo CA, Pisko EJ. Increased incidence of recurrent hematuria in ankylosing spondylitis: a possible association with IgA nephropathy. Rheumatol Int 1984;4:27-9.
- Calin A. Rarity of nephropathy in ankylosing spondylitis. Arthritis Rheum. 1982;25:1510.
- Levy-Clarke G, Nussenblatt R. Does anti-TNF therapy decrease the incidence of anterior uveitis in patients with ankylosing spondylitis? Nat Clin Pract Rheumatol 2006;2:72–3.
- Elewaut D, Matucci-Cerinic M. Treatment of ankylosing spondylitis and extraarticular manifestations in everyday rheumatology practice. Rheumatology (Oxford) 2009;48:1029–35.
- Song IH, Appel H, Haibel H, Loddenkemper C, Braun J, Sieper J. et al. New onset of Crohn’s disease during treatment of active ankylosing spondylitis with etanercept. J Rheumatol 2008;35:532–6.
- Braun J, Baraliakos X, Listing J, Davis J, van der Heijde D, Haibel H. et al. Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents. Arthritis Rheum 2007;57:639–47.
- Reynolds TL, Khan MA, Van der Linden S, Cleveland RP. Differences in HLA-B27 positive and negative patients with ankylosing spondylitis: study- of clinical disease activityaild concentration of serum IgA, C reactive protein, and, haptoglobin. Ann Rheum Dis 1991;50:154-7.
- Kobak S, Oksel F, Kabasakal Y, Doganavsargil E. Ankylosing spondylitis- related secondary amyloidosis responded well to etanercept: a report of three patients. Clin Rheumatol 2007;26:2191–4.
There are 16 citations in total.
Details
| Primary Language | English |
|---|---|
| Journal Section | Research Article |
| Authors | |
| Publication Date | December 1, 2014 |
| Published in Issue | Year 2014Issue: 4 |